SCHEMBL360591

SCHEMBL360591

CC(C(=O)O)c1ccccc1Nc1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCL8 P10145 5/20 0.65
MAPT P10636 6/20 0.50
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
ALDH1A1 P00352 3/20 0.50
RXFP1 Q9HBX9 1/20 0.50
ALOX15 P16050 2/20 0.49
FABP4 P15090 1/20 0.47
LMNA P02545 2/20 0.46
HPGD P15428 2/20 0.46
POLB P06746 1/20 0.46
GFER P55789 1/20 0.45
NGLY1 Q96IV0 1/20 0.45
HSD17B10 Q99714 3/20 0.44
THRB P10828 2/20 0.44
RECQL P46063 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
CYP3A4 P08684 1/20 0.44
TSHR P16473 1/20 0.44
ALOX12 P18054 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27800319 0.89 CXCL8 (0.53) CXCL8MAPTMEN1KMT2AALDH1A1
SCHEMBL16539266 0.86 CXCL8 (0.64) CXCL8MAPTMEN1KMT2AALDH1A1
SCHEMBL14280730 0.84 CXCL8 (0.63) CXCL8MAPTMEN1KMT2AALDH1A1
SCHEMBL4944935 0.80 CXCL8 (0.58) CXCL8MAPTKMT2AALDH1A1LMNA
SCHEMBL30285203 0.79 ALDH1A1 (0.53) CXCL8MAPTMEN1KMT2AALDH1A1
SCHEMBL3137707 0.79 CXCL8 (1.00) CXCL8MAPTMEN1KMT2ALMNA
SCHEMBL3151521 0.79 CXCL8 (1.00) CXCL8MAPTMEN1KMT2ALMNA
SCHEMBL12129515 0.79 CXCL8 (1.00) CXCL8MAPTMEN1KMT2ALMNA
SCHEMBL7979001 0.79 TDP1 (0.50) MAPTMEN1KMT2AALDH1A1ALOX15
SCHEMBL187738 0.79 CXCL8 (0.56) CXCL8MAPTALDH1A1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012008916-A1 FLAME RETARDANT AND INTUMESCENT COMPOUND AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2012-01-19 WO disclosed
US-7034187-B2 Poly(aralkyl ketone)s and methods of preparing the same AGENCY FOR SCIENCE, TECHNOLOGY, AND RESEARCH (SG) 2006-04-25 US disclosed
US-20050272905-A1 NOVEL POLY(ARALKYL KETONE)S AND METHODS OF PREPARING THE SAME AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH 2005-12-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050272905-A1 NOVEL POLY(ARALKYL KETONE)S AND METHODS OF PREPARING THE SAME ADSL, KHK, PKLR CXCL8 3796/4885MAPT 3173/4885MEN1 2585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.